scholarly journals Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer

2008 ◽  
Vol 105 (35) ◽  
pp. 13021-13026 ◽  
Author(s):  
J. A. Foekens ◽  
A. M. Sieuwerts ◽  
M. Smid ◽  
M. P. Look ◽  
V. de Weerd ◽  
...  
1989 ◽  
Vol 4 (3) ◽  
pp. 157-162 ◽  
Author(s):  
S. Barni ◽  
P. Lissoni ◽  
A. Sormani ◽  
F. Pelizzoni ◽  
F. Brivio ◽  
...  

Several studies have suggested that the pineal gland hormone melatonin may influence the growth of breast cancer. The importance of melatonin blood concentrations in the clinical history of human breast cancer, however, has still to be defined. To further investigate this problem, we used a RIA method to assay serum levels of the pineal hormone in 74 untreated breast cancer patients, clinical stage T1–3 NO-2 MO, and in 46 age-matched healthy women as controls. Mean serum melatonin levels were significantly higher inpatients than in controls. Melatonin concentrations were highest in breast cancer patients with the best prognosis (i.e. estrogen receptor-positive/node-negative cases). Mean levels of melatonin were significantly higher in estrogen receptor-positive patients than in the negative ones. They were also higher in node-negative than in node-positive cases, and in progesterone receptor-positive patients than negative ones, but none of these differences was statistically significant. No difference was observed in relation to menopausal status and to tumor histotype. These results suggest that melatonin plays a role in the hormone-dependency of human breast cancer.


Sign in / Sign up

Export Citation Format

Share Document